{"meta":{"query_hash":"c281624b7d2e","filters":{"venue":"Journal of Central Nervous System Disease"},"cohort_total":14,"direct_labels_cover":0,"predictions_cover":14,"exported":14,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/c281624b7d2e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Central+Nervous+System+Disease"},"results":[{"id":"W1981640307","doi":"10.4137/jcnsd.s5120","title":"Safety and Efficacy of Fingolimod in Treatment-Naïve Multiple Sclerosis Patients","year":2011,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Fingolimod; Multiple sclerosis; Medicine; Relapsing remitting; Adverse effect; Disease; Intensive care medicine; Physical therapy; Internal medicine; Immunology","score_opus":0.05738348288276247,"score_gpt":0.2646738614946622,"score_spread":0.20729037861189975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981640307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977035,0.0010380998,0.000017112614,0.00007046707,0.0001451655,0.00064981147,0.00008388548,0.000011504069,0.00028046014],"genre_scores_gemma":[0.9986154,0.0009860031,0.00022342996,0.000014523531,0.00010282181,0.0000063701987,0.000006283397,0.00002169172,0.000023489909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977854,0.00015841139,0.0009014555,0.00018837702,0.00053386553,0.00043247576],"domain_scores_gemma":[0.9981099,0.00016615124,0.00045133394,0.00022390291,0.0003047374,0.00074400014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021215883,0.00020461557,0.0007209224,0.00024836726,0.000060054226,0.000011188212,0.00011303471,0.000052254418,0.000023900717],"category_scores_gemma":[0.0006040006,0.00014316631,0.0002552572,0.00017678637,0.00010604765,0.00013863214,0.000056320117,0.00013387836,0.0000027029819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008736561,0.0021589634,0.9717928,0.0005538021,0.00031905455,0.00014007803,0.001768993,0.000034283334,0.0006621926,0.000019354778,0.00006716076,0.013746717],"study_design_scores_gemma":[0.0139857605,0.000884442,0.98193705,0.0015516328,0.00017425041,0.0000091719185,0.00042823862,0.00039437623,0.00046280678,0.0000015364064,0.00006831322,0.000102431644],"about_ca_topic_score_codex":0.0002736951,"about_ca_topic_score_gemma":0.000032967913,"teacher_disagreement_score":0.0136442855,"about_ca_system_score_codex":0.00041887045,"about_ca_system_score_gemma":0.00017751177,"threshold_uncertainty_score":0.5838153},"labels":[],"label_agreement":null},{"id":"W2017914285","doi":"10.4137/jcnsd.s13570","title":"Medical Treatment of Essential Tremor","year":2014,"lang":"en","type":"review","venue":"Journal of Central Nervous System Disease","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"Royal University Hospital Foundation","keywords":"Primidone; Essential tremor; Clonazepam; Medicine; Postural tremor; Propranolol; Physical medicine and rehabilitation; Resting tremor; Physical therapy; Anesthesia; Psychiatry; Parkinsonism; Carbamazepine; Internal medicine; Epilepsy; Disease","score_opus":0.02513982043360828,"score_gpt":0.3227824312657201,"score_spread":0.2976426108321118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017914285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015202805,0.99611807,0.000031265317,0.00018051954,0.0008733457,0.0008472448,0.00008218614,0.000021044758,0.00032602943],"genre_scores_gemma":[0.022157243,0.9763305,0.000021667802,0.000059140624,0.0011021532,0.000016090407,0.000052507745,0.000055084,0.00020561561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959148,0.0003821873,0.0018476654,0.00029826546,0.0011124433,0.00044464262],"domain_scores_gemma":[0.99592537,0.00015511918,0.0016355789,0.00039178442,0.00015058508,0.0017415842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015760426,0.00051452,0.0040153135,0.00021464174,0.000042779473,0.00001811522,0.00023645531,0.00028285116,0.0002288498],"category_scores_gemma":[0.00014777532,0.000273816,0.0028237216,0.00016640133,0.00009651946,0.000038320224,0.000028076045,0.00023142848,0.00002924181],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001030743,0.0041832463,0.0005222921,0.051432308,0.0022012722,0.01666813,0.00002168718,0.0000022895056,3.3330886e-7,0.00015906265,0.0011799288,0.9225987],"study_design_scores_gemma":[0.009147393,0.006024268,0.0017050272,0.05479288,0.0325038,0.0027899402,0.000028358676,0.00006709268,0.00000213028,0.000040252533,0.89239866,0.0005001958],"about_ca_topic_score_codex":0.000011780276,"about_ca_topic_score_gemma":0.0000010605122,"teacher_disagreement_score":0.9220985,"about_ca_system_score_codex":0.00031099675,"about_ca_system_score_gemma":0.0012946362,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W2113626944","doi":"10.4137/jcnsd.s1611","title":"Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications","year":2011,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health; 3M (Canada); Amgen (Canada)","funders":"Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Insomnia; Melatonin; Medicine; Placebo; Pharmacology; Psychology; Anesthesia; Internal medicine","score_opus":0.033625781253356954,"score_gpt":0.2885577998119702,"score_spread":0.25493201855861325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113626944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593997,0.0012423508,0.0011399395,0.00010890283,0.00029133327,0.00048712827,0.0000430413,0.00002388066,0.00072344113],"genre_scores_gemma":[0.9987817,0.00052202755,0.00019324993,0.0001406805,0.00028478875,0.0000045319794,4.952347e-7,0.000020379148,0.0000521907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827653,0.00020388966,0.0007539309,0.00019934401,0.00031025292,0.00025603373],"domain_scores_gemma":[0.99812585,0.00014751995,0.0006508673,0.00020880625,0.00008637354,0.00078055495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002406201,0.00013769366,0.00035545524,0.000087486376,0.00007589148,0.000020557385,0.00021499707,0.000044117478,0.00003697898],"category_scores_gemma":[0.000049301107,0.00009901869,0.0001503082,0.00017286933,0.00018984627,0.00016684069,0.000019939253,0.00018995164,0.0000068629884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03917326,0.009579386,0.61596274,0.0026551497,0.0007546311,0.004899117,0.0052384506,0.0004152852,0.06469628,0.1007466,0.0014681063,0.154411],"study_design_scores_gemma":[0.010763244,0.0009738906,0.9465458,0.0007162069,0.0005744033,0.0012498349,0.00028505395,0.0003300543,0.027165707,0.000080537975,0.010892367,0.0004229304],"about_ca_topic_score_codex":0.0000052624673,"about_ca_topic_score_gemma":6.7174796e-7,"teacher_disagreement_score":0.33058304,"about_ca_system_score_codex":0.00003986303,"about_ca_system_score_gemma":0.0002213694,"threshold_uncertainty_score":0.4037865},"labels":[],"label_agreement":null},{"id":"W3001091229","doi":"10.1177/1179573519899471","title":"The Impact of Rehabilitation-oriented Virtual Reality Device in Patients With Ischemic Stroke in the Early Subacute Recovery Phase: Study Protocol for a Phase III, Single-Blinded, Randomized, Controlled Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Rehabilitation; Randomized controlled trial; Medicine; Protocol (science); Physical therapy; Physical medicine and rehabilitation; Stroke (engine); Ischemic stroke; Clinical trial; Single blind; Surgery; Ischemia; Internal medicine; Alternative medicine; Pathology; Engineering","score_opus":0.0393145318843309,"score_gpt":0.3909628404873979,"score_spread":0.35164830860306695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001091229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7912766,0.000028491057,0.00025408284,0.00056172983,0.00021448448,0.20755053,0.00008786676,0.000008637953,0.000017624072],"genre_scores_gemma":[0.97595185,0.0000018221934,0.0000524748,0.000057770234,0.00039606326,0.023494164,0.00001202038,0.000023493827,0.000010332218],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99124,0.003073846,0.0039434345,0.00030252556,0.0010511938,0.0003889976],"domain_scores_gemma":[0.9883927,0.00736735,0.0024851027,0.0003453902,0.00090984296,0.000499615],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005555801,0.00030282134,0.0023516582,0.00018696101,0.000084773266,0.000065492706,0.00025269928,0.000097858756,0.000007855561],"category_scores_gemma":[0.009128359,0.00013209783,0.0018490287,0.0004144159,0.00019779615,0.0002503939,0.000018562327,0.00044937243,4.1390604e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8841078,0.014972931,0.09654893,0.000241212,0.0008740608,0.000033102206,0.0015135644,0.0002167215,0.00001847305,0.000008952566,0.00036595197,0.0010982478],"study_design_scores_gemma":[0.8719394,0.052449357,0.069618694,0.0005488596,0.00073561847,0.0000032995185,0.0035157283,0.0010197215,0.0000022270872,0.0000030136982,0.00004911583,0.00011494548],"about_ca_topic_score_codex":0.00006290802,"about_ca_topic_score_gemma":0.00001437643,"teacher_disagreement_score":0.1846753,"about_ca_system_score_codex":0.00035214063,"about_ca_system_score_gemma":0.0011721262,"threshold_uncertainty_score":0.99921817},"labels":[],"label_agreement":null},{"id":"W3109019868","doi":"10.1177/1179573520973819","title":"Atypical Neuromyelitis Optica Spectrum Disorder With Diffuse Cerebral Abnormalities: A Case Report","year":2020,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuromyelitis optica; Medicine; Spectrum disorder; Aquaporin 4; Spinal cord; White matter; Neuroimaging; Hyperintensity; Pathology; Myelopathy; Magnetic resonance imaging; Radiology; Multiple sclerosis; Immunology; Psychiatry","score_opus":0.021991281671635995,"score_gpt":0.25659342764011356,"score_spread":0.23460214596847756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109019868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803167,0.00073029473,0.00064746494,0.016715473,0.00024634943,0.00071524485,0.000088766195,0.00008438692,0.00045532695],"genre_scores_gemma":[0.9973777,0.00008393359,0.00035542718,0.0004414817,0.0015146447,0.0000146243765,0.000010859699,0.000059231923,0.00014209966],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9961633,0.00022176407,0.0011013317,0.00037435486,0.0012902612,0.00084899913],"domain_scores_gemma":[0.9955838,0.00013573788,0.0005066248,0.00040004586,0.00035729495,0.0030165107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023363749,0.00035152532,0.00090706965,0.000118427815,0.00018806572,0.000108206776,0.00019938374,0.000060943934,0.00013331656],"category_scores_gemma":[0.00086750457,0.00022749172,0.00045233764,0.00029263934,0.00019866829,0.00027176383,0.00011669864,0.00053286937,0.00001574856],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009760462,0.0006852664,0.15605564,0.0023946734,0.000648794,0.82455415,0.0013322213,0.00028646976,0.00008411382,0.00036610343,0.0032821426,0.00054996967],"study_design_scores_gemma":[0.0112268645,0.0024972917,0.7352667,0.0014969101,0.0009776762,0.23383944,0.0044740234,0.0036621955,0.0000542316,0.000007325514,0.005995314,0.0005020457],"about_ca_topic_score_codex":0.000108483546,"about_ca_topic_score_gemma":0.00002693325,"teacher_disagreement_score":0.5907147,"about_ca_system_score_codex":0.00025001276,"about_ca_system_score_gemma":0.0006127001,"threshold_uncertainty_score":0.9276843},"labels":[],"label_agreement":null},{"id":"W3178503731","doi":"10.1177/11795735211029114","title":"Salivary Heme Oxygenase-1: A Potential Biomarker for Central Neurodegeneration","year":2021,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Parkinson Canada; Mitacs","keywords":"Biomarker; Neurodegeneration; Medicine; Saliva; Internal medicine; Population; Parkinson's disease; Gastroenterology; Degenerative disease; Pathology; Heme oxygenase; Disease; Heme; Biology; Biochemistry","score_opus":0.009466947513216278,"score_gpt":0.22789886731968415,"score_spread":0.21843191980646787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178503731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97658545,0.0036608032,0.017008448,0.00045977923,0.0016937953,0.00027783823,0.00019882314,0.000015569056,0.000099484954],"genre_scores_gemma":[0.99615836,0.00013561445,0.00068225036,0.00039406918,0.001957147,0.0000123479795,0.00025792522,0.000047380367,0.00035487587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978391,0.00021246917,0.00068169355,0.00033579668,0.00035043692,0.0005805122],"domain_scores_gemma":[0.998116,0.0000108120585,0.00034979708,0.00033211467,0.00041153637,0.00077969965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020812385,0.00024115741,0.00030599962,0.000058384012,0.000116558185,0.00009745929,0.0002113586,0.00012314525,0.000023722585],"category_scores_gemma":[0.00011334534,0.00022036678,0.00062881655,0.00010440118,0.000032358694,0.000018810095,0.000055581695,0.00009350933,0.0000027664864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013542114,0.000276738,0.0019421331,0.00032132887,0.0002530563,0.0008829746,0.000023185927,0.0014931,0.9765464,0.00017559924,0.015245344,0.0014859299],"study_design_scores_gemma":[0.009354872,0.001033274,0.16714121,0.000489093,0.0013211023,0.0023552156,0.0008481726,0.011831615,0.74423856,0.0001102726,0.059695344,0.0015812982],"about_ca_topic_score_codex":0.0000055191517,"about_ca_topic_score_gemma":0.000008225511,"teacher_disagreement_score":0.23230787,"about_ca_system_score_codex":0.00007607644,"about_ca_system_score_gemma":0.00072276266,"threshold_uncertainty_score":0.89862967},"labels":[],"label_agreement":null},{"id":"W3191178877","doi":"10.1177/11795735211028781","title":"Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies","year":2021,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Placebo; Internal medicine; Post-hoc analysis; Age groups; Adverse effect; Pooled analysis; Demography; Confidence interval; Immunology; Pathology; Fingolimod","score_opus":0.056987497143042534,"score_gpt":0.32400585070450566,"score_spread":0.26701835356146314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191178877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853489,0.013285841,0.000024797435,0.00047029223,0.00013077018,0.0003875586,0.00030807004,0.000014566272,0.000029246672],"genre_scores_gemma":[0.99169236,0.0076176855,0.00033430423,0.000034305507,0.00021712783,0.000008526044,0.00002581606,0.000022896986,0.00004696752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966944,0.00037934558,0.0013124087,0.00037450084,0.00070172176,0.00053761515],"domain_scores_gemma":[0.99722326,0.0007034963,0.0005409955,0.00032559273,0.0004481176,0.0007585392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005841592,0.00027488408,0.0016459526,0.00033515136,0.00014305946,0.000065780856,0.00012044501,0.000056068584,0.000012929977],"category_scores_gemma":[0.001237808,0.00021300056,0.00038179898,0.00077735353,0.00029003542,0.00018249202,0.0002481034,0.00026219263,6.1663485e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006327998,0.0005308124,0.9576615,0.0012155137,0.0048443307,0.0019591954,0.002726824,0.00026076252,0.021069285,0.000012219437,0.000088715526,0.0033028107],"study_design_scores_gemma":[0.008892394,0.00012331705,0.9794107,0.002507717,0.0020749543,0.000014827975,0.0055165407,0.00066069583,0.00061168935,0.000004325461,0.000023668454,0.0001591455],"about_ca_topic_score_codex":0.00072087476,"about_ca_topic_score_gemma":0.0021507626,"teacher_disagreement_score":0.021749191,"about_ca_system_score_codex":0.00035074595,"about_ca_system_score_gemma":0.00016430183,"threshold_uncertainty_score":0.86859107},"labels":[],"label_agreement":null},{"id":"W4393234802","doi":"10.1177/11795735241241423","title":"Meningoencephalitis in a novel mutation in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy) ending a familial diagnostic odyssey: A case series report","year":2024,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Exome sequencing; Genetics; Thymidine phosphorylase; Meningoencephalitis; Population; Medicine; Biology; Phenotype; Pathology; Gene; Cancer","score_opus":0.00966804753211572,"score_gpt":0.25991903318878906,"score_spread":0.25025098565667336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393234802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398184,0.0016632063,0.0029625343,0.00019468954,0.0007436682,0.00031464855,0.000054982953,0.0000137320285,0.00007071199],"genre_scores_gemma":[0.99846834,0.0000409902,0.0005304132,0.000020754644,0.00078184076,0.000028983835,0.0000429942,0.000027970405,0.00005772515],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9977643,0.00015598214,0.00077977247,0.00038709253,0.00039992845,0.0005129196],"domain_scores_gemma":[0.99901956,0.000069653106,0.00017505336,0.00018500444,0.00012473775,0.00042598718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032759728,0.00021164474,0.0002685674,0.00021260706,0.00004430827,0.00011565029,0.00018158638,0.00008908059,0.000005833318],"category_scores_gemma":[0.0012598525,0.00019005538,0.00022059202,0.0002578326,0.000078650606,0.000036382306,0.00008668471,0.00031305416,0.0000015814517],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010385318,0.00025593422,0.007310777,0.0006109246,0.00004858204,0.48324975,0.0002936243,0.0007385479,0.50466347,0.00031645113,0.0001256891,0.0013477311],"study_design_scores_gemma":[0.0068678656,0.0027678192,0.042138353,0.007221372,0.00034467122,0.8677822,0.0023081235,0.00600868,0.05960439,0.00021727456,0.0035031687,0.0012361223],"about_ca_topic_score_codex":0.00012157905,"about_ca_topic_score_gemma":0.00007104173,"teacher_disagreement_score":0.44505906,"about_ca_system_score_codex":0.00019565012,"about_ca_system_score_gemma":0.00081730087,"threshold_uncertainty_score":0.77502334},"labels":[],"label_agreement":null},{"id":"W4396662992","doi":"10.1177/11795735241249693","title":"From progression to progress: The future of multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Novartis (Canada); Montreal Neurological Institute and Hospital; University of Calgary; St. Michael's Hospital","funders":"Novartis Pharmaceuticals Canada","keywords":"Disease; Medicine; Intensive care medicine; Mechanism (biology); Personalized medicine; Multiple sclerosis; Precision medicine; Biomarker; Biomarker discovery; Bioinformatics; Pathology; Psychiatry","score_opus":0.03025670588610446,"score_gpt":0.30708981411917313,"score_spread":0.27683310823306867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396662992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92780054,0.056257706,0.00014104231,0.012415832,0.0017350512,0.0013069921,0.00021592678,0.00006981341,0.000057112607],"genre_scores_gemma":[0.99519837,0.00048277713,0.00073205394,0.00006698027,0.0033930135,0.000039008333,0.000008301388,0.000036201174,0.000043288255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969612,0.00020032511,0.0007744321,0.00023888319,0.0013669432,0.0004582202],"domain_scores_gemma":[0.9977834,0.00020525047,0.00026084506,0.0003678131,0.00045731518,0.00092533114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045674012,0.00021560464,0.00054323644,0.00018028756,0.000115001356,0.00010465053,0.000311573,0.00006186909,0.000041947314],"category_scores_gemma":[0.00027278354,0.00010976064,0.00046861227,0.00041054215,0.00012544931,0.00015309772,0.00012273421,0.0003392437,0.000018318102],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011105359,0.0016485129,0.35739407,0.010287677,0.0022463673,0.0025400491,0.009801124,0.00028310606,0.034567032,0.00023645225,0.07161312,0.49827713],"study_design_scores_gemma":[0.0018599926,0.0005715164,0.9569477,0.017080938,0.0006083347,0.000052312535,0.0039393874,0.0027096595,0.0021564404,0.000014165199,0.013873703,0.00018586143],"about_ca_topic_score_codex":0.00002652399,"about_ca_topic_score_gemma":0.0000068869444,"teacher_disagreement_score":0.5995536,"about_ca_system_score_codex":0.00031326193,"about_ca_system_score_gemma":0.0005501154,"threshold_uncertainty_score":0.4475909},"labels":[],"label_agreement":null},{"id":"W4401921750","doi":"10.1177/11795735241274186","title":"Diagnostic value of soluble Interleukin-2 receptor in patients suffering neurosarcoidosis: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of Central Nervous System Disease","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sächsische Landesbibliothek – Staats- und Universitätsbibliothek Dresden; Technische Universität Dresden; Deutsche Forschungsgemeinschaft","keywords":"Neurosarcoidosis; Medicine; Cochrane Library; Internal medicine; Sarcoidosis; MEDLINE; Randomized controlled trial; Systematic review","score_opus":0.024895782645933087,"score_gpt":0.32193805968863937,"score_spread":0.2970422770427063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401921750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019832316,0.99136883,0.0000030965252,0.00010324465,0.0015282052,0.004828751,0.00012650905,0.000027981096,0.000030145115],"genre_scores_gemma":[0.020248298,0.9787876,0.00001727624,0.00006752104,0.00039170787,0.0001688198,0.000048757796,0.00014445966,0.00012557147],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9906769,0.001296332,0.004903165,0.00048812787,0.0018310989,0.0008044123],"domain_scores_gemma":[0.99459386,0.00067587115,0.002350459,0.00075803016,0.00050927856,0.0011124861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015181532,0.00073209073,0.007307878,0.00095476914,0.00004031174,0.00009505833,0.00070619304,0.000226182,0.000038258375],"category_scores_gemma":[0.003330675,0.0004627265,0.0028582222,0.0010476727,0.00007187112,0.00017337168,0.00021463804,0.001190618,0.00008082645],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012312629,0.0007948189,0.0008600046,0.9905241,0.0007308388,0.0011248025,0.000043658667,0.0000021861576,0.0000011963816,0.000027317867,0.0017312842,0.004036659],"study_design_scores_gemma":[0.0007511028,0.0005090148,0.00054353796,0.975185,0.018024137,0.00030105078,0.00003925076,0.000031987714,0.0000013539747,0.0000013465313,0.004298757,0.00031349537],"about_ca_topic_score_codex":0.000021925951,"about_ca_topic_score_gemma":0.000001608893,"teacher_disagreement_score":0.018265065,"about_ca_system_score_codex":0.001285939,"about_ca_system_score_gemma":0.0014814474,"threshold_uncertainty_score":0.99978244},"labels":[],"label_agreement":null},{"id":"W4403886581","doi":"10.1177/11795735241292185","title":"Measurement of cerebral venous oxygenation with quantitative susceptibility mapping after subarachnoid hemorrhage: A pilot study","year":2024,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China; National Science Foundation","keywords":"Subarachnoid hemorrhage; Oxygenation; Medicine; Anesthesia; Cardiology","score_opus":0.027799711764195368,"score_gpt":0.25768959373575157,"score_spread":0.2298898819715562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403886581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370474,0.002367487,0.0018109338,0.0006424741,0.00026011205,0.0010341032,0.000030957937,0.00004898886,0.000100214296],"genre_scores_gemma":[0.99927044,0.0000028978475,0.00039562615,0.000024732582,0.00020196538,0.000035261997,0.000005751863,0.000025272675,0.000038055525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772424,0.00015119583,0.0007024967,0.00023656816,0.0009202062,0.0002653138],"domain_scores_gemma":[0.9983529,0.000026979214,0.00028934743,0.00024777153,0.000753395,0.0003296007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004186976,0.00020193387,0.00044259508,0.00019973418,0.00007474519,0.000052148338,0.00010262271,0.000021998254,0.00003078984],"category_scores_gemma":[0.00004599598,0.00013517543,0.00018233956,0.00030994427,0.000048899332,0.00018382342,0.000015872567,0.00018428094,0.000010911849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06072538,0.050473504,0.7709012,0.027919874,0.0038212824,0.031508397,0.012708375,0.0010977588,0.028653929,0.0032293014,0.00031687244,0.008644127],"study_design_scores_gemma":[0.0023803606,0.0112271765,0.9759459,0.0011654666,0.0019893933,0.0006585812,0.003484083,0.0026910654,0.00021510312,0.000041821957,0.000015072571,0.00018599536],"about_ca_topic_score_codex":0.000053653588,"about_ca_topic_score_gemma":0.000042663123,"teacher_disagreement_score":0.20504469,"about_ca_system_score_codex":0.00054326345,"about_ca_system_score_gemma":0.00050340313,"threshold_uncertainty_score":0.5512294},"labels":[],"label_agreement":null},{"id":"W4407388582","doi":"10.1177/11795735251314881","title":"Prevalence and outcomes of mild stroke patients undergoing reperfusion therapy: A meta-analysis and SAFE recommendations for optimal management","year":2025,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Government of Canada; Fondazione Cariplo; Canadian Institutes of Health Research; Australian Academy of Science; National Cerebral and Cardiovascular Center","keywords":"Medicine; Thrombolysis; Stroke (engine); Intracerebral hemorrhage; Meta-analysis; Adverse effect; Odds ratio; Internal medicine; Reperfusion therapy; Cochrane Library; MEDLINE; Physical therapy; Subarachnoid hemorrhage; Ischemia; Myocardial infarction","score_opus":0.023457493685736647,"score_gpt":0.2889573724599556,"score_spread":0.265499878774219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407388582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813901,0.0050862026,0.007413604,0.0039399555,0.00018391556,0.0013786912,0.00018307408,0.000013317633,0.0004111176],"genre_scores_gemma":[0.99109185,0.0011084274,0.0059462134,0.00025168713,0.000020691521,0.000024969044,0.000013489384,0.000010471801,0.001532232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983537,0.00007876252,0.000791705,0.00021780295,0.00035548408,0.00020254489],"domain_scores_gemma":[0.9986113,0.00012823437,0.0005792624,0.000249923,0.00020855448,0.00022277422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003371296,0.00017329869,0.0008241171,0.00038405406,0.00007919854,0.00002809594,0.000106732536,0.00003202764,0.000027013948],"category_scores_gemma":[0.00007046079,0.000120266304,0.00069041934,0.00019131564,0.000034022964,0.00010643835,0.00009004658,0.000072126124,1.301129e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019660778,0.00064929144,0.8500537,0.0050502894,0.13061829,0.000037152106,0.00020526006,0.00024993694,0.00008196106,0.0004276041,0.0055128797,0.005147539],"study_design_scores_gemma":[0.0050676283,0.00031863153,0.7743521,0.0003872809,0.21680585,0.0000040360933,0.0007299308,0.0009191166,0.0001734606,0.0000101971245,0.0010893901,0.00014238173],"about_ca_topic_score_codex":0.00000629314,"about_ca_topic_score_gemma":0.0000013111874,"teacher_disagreement_score":0.08618756,"about_ca_system_score_codex":0.00011235585,"about_ca_system_score_gemma":0.00005421955,"threshold_uncertainty_score":0.49043176},"labels":[],"label_agreement":null},{"id":"W4408345465","doi":"10.1177/11795735251322456","title":"<i>Bartonella henselae</i> , <i>Babesia odocoilei</i> and <i>Babesia divergens</i> -like MO-1 infection in the brain of a child with seizures, mycotoxin exposure and suspected Rasmussen's encephalitis","year":2025,"lang":"en","type":"article","venue":"Journal of Central Nervous System Disease","topic":"Bartonella species infections research","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"State of North Carolina; Steven and Alexandra Cohen Foundation","keywords":"Bartonella; Biology; Encephalitis; Virology; Bartonella henselae; Babesia; Serology; Polymerase chain reaction; Immunology; Antibody","score_opus":0.0037667807770797846,"score_gpt":0.21097204315102333,"score_spread":0.20720526237394354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408345465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840046,0.012354604,0.00014229603,0.0013255858,0.0004883253,0.0007620881,0.00007409286,0.00003111905,0.00081725826],"genre_scores_gemma":[0.9978804,0.001262166,0.000016758333,0.0003231642,0.000075421296,0.000023100296,0.000015041662,0.000020740525,0.00038319518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681133,0.001202549,0.00084398576,0.00034032413,0.00022601668,0.0005757781],"domain_scores_gemma":[0.99842703,0.00038770988,0.00042057157,0.00033511812,0.00028161157,0.00014797709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000719684,0.00031431936,0.00062967197,0.00038559863,0.00033499702,0.00007843009,0.00027609293,0.00020235853,0.0000422147],"category_scores_gemma":[0.00014282376,0.00021535551,0.00016273942,0.0007094755,0.0005106176,0.0002128257,0.00010395756,0.0006943545,0.000004439152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00789738,0.0021946905,0.814817,0.0031940192,0.0019859474,0.002348017,0.0035773327,0.00086382317,0.0805579,0.012894913,0.065977596,0.0036913622],"study_design_scores_gemma":[0.0082397945,0.0010653753,0.9521834,0.0020312902,0.00053066545,0.007412854,0.0025721386,0.000054229924,0.004300199,0.00012431553,0.021001797,0.0004839188],"about_ca_topic_score_codex":0.00033933957,"about_ca_topic_score_gemma":0.00019805098,"teacher_disagreement_score":0.1373664,"about_ca_system_score_codex":0.00014533704,"about_ca_system_score_gemma":0.0002530002,"threshold_uncertainty_score":0.8781943},"labels":[],"label_agreement":null},{"id":"W4415174656","doi":"10.1177/11795735251388781","title":"Fecal Microbiota Transplantation for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2025,"lang":"en","type":"review","venue":"Journal of Central Nervous System Disease","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Randomized controlled trial; Fecal bacteriotherapy; Feces; Transplantation; Clinical endpoint; Dysbiosis","score_opus":0.041363920535136635,"score_gpt":0.3543064985028668,"score_spread":0.3129425779677301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415174656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039527007,0.9803183,0.0005472343,0.00007846627,0.00012945646,0.013476103,0.005404535,0.0000028834063,0.000003496346],"genre_scores_gemma":[0.0020659198,0.9959813,0.00008286507,0.000042835585,0.00007502326,0.000756845,0.00074762636,0.000025916299,0.00022168658],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98770136,0.004782632,0.006623272,0.00035771486,0.00025157208,0.00028347902],"domain_scores_gemma":[0.9886605,0.0012338456,0.008771236,0.0004492253,0.0004647388,0.0004204564],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.003920968,0.000593099,0.038089655,0.0004383124,0.00004809055,0.000029058725,0.0002404402,0.00019460781,0.000013887594],"category_scores_gemma":[0.0011820034,0.0003036558,0.024354042,0.00024126587,0.0000680287,0.000005779065,0.000014531,0.00005307049,1.5946327e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016828336,0.00019870997,8.630722e-7,0.7303935,0.252243,0.0000137544175,0.000012676332,0.0000081257285,0.00003560746,0.00002870828,0.00008956059,0.00014712235],"study_design_scores_gemma":[0.031274263,0.0001496966,0.0000053675135,0.07070058,0.89528877,0.000023853372,0.000008402039,0.0000072625376,0.0000056992194,9.773846e-7,0.0023503671,0.00018476986],"about_ca_topic_score_codex":0.000007423173,"about_ca_topic_score_gemma":0.0000047122267,"teacher_disagreement_score":0.65969294,"about_ca_system_score_codex":0.0001045603,"about_ca_system_score_gemma":0.0012950852,"threshold_uncertainty_score":0.9999415},"labels":[],"label_agreement":null}]}